Investor Overview At Gilead we are inspired by the opportunity to address unmet medical needs for patients living with life-threatening diseases around the world. Stock Quote Stock Quote Volume: Jan 23, 2019 3:03 PM EST Latest News January 22, 2019 Gilead Sciences to Release Fourth Quarter and Full Year 2018 Financial Results on Monday, February 4, 2019 January 8, 2019 Japan’s Ministry of Health, Labour and Welfare Approves Gilead’s Epclusa® (Sofosbuvir/Velpatasvir) January 6, 2019 Gilead Sciences and Yuhan Corporation Announce Collaboration and License Agreement to Develop Novel Investigational Treatments for Advanced Fibrosis Due to Nonalcoholic Steatohepatitis View All Events Feb 4, 2019 at 4:30 PM EST Fourth Quarter 2018 Gilead Sciences Earnings Conference Call Jan 7, 2019 at 9:30 AM PST Gilead Sciences at the 37th Annual J.P. Morgan Healthcare Conference Nov 27, 2018 at 9:30 AM EST Gilead Sciences at the Evercore ISI HealthCONx Conference View All
